Home > Press > Nanotechnology Community to Come Together at Advanced Therapeutics Symposium
The Nano Science and Technology Institute (NSTI) Invites Researchers to Submit Abstracts for the Merck Corporate Symposium on Targeted Delivery of siRNA, Taking Place During Nanotech 2008 in Boston, MA, USA
Nanotechnology Community to Come Together at Advanced Therapeutics Symposium
Boston, MA | Posted on November 26th, 2007
The Nano Science and Technology Institute (NSTI) is pleased to announce that abstracts are being accepted for the Merck Corporate Symposium: Targeted Delivery of siRNA, which will be held exclusively during NSTI Nanotech 2008 June 1-5 in Boston, MA. The Symposium will provide a significant platform for Merck to engage leading researchers in the nano tech community and focus discussion around the application of emerging nano technologies and their ability to affect targeted delivery of therapeutic siRNA molecules.
The Merck Corporate Symposium will focus on enabling technologies that can be applied to the efficient delivery of siRNA in vivo which results in reduced levels of specific mRNAs/proteins. In addition, technologies useful for the accelerated development of siRNA containing therapeutics are relevant. Specific areas of interest include:
• Biodegradable delivery components with low levels of toxicity
• Delivery systems for multiple tissues
• Delivery approaches amenable to alternate routes of administration
• Enhanced siRNA delivery using molecular targeting strategies
• Improved siRNA intracellular trafficking, endosomal escape and RISC incorporation
• Advanced siRNA structures which improve in vivo potency, stability, duration of action, specificity and toxicity profiles
• Whole animal methods for efficiently evaluating biodistribution and gene silencing
• Analytical methods for the physical and chemical characterization of complex assemblies
"Merck is pleased to partner with the NSTI in bringing the Symposium to Boston," said Dr. Reid Leonard, Merck's Executive Director of Licensing and External Research. "Nanotech 2008 reflects our commitment to innovation and provides an ideal forum for the presentation of siRNA enabling technologies - an area where Merck has assumed a leadership role."
Entering its 11th year, Nanotech 2008 is the world's largest and most comprehensive technical and business event in nanotechnology. "Merck's Corporate Symposium is one of the most anticipated programs at next year's conference," noted Dr. Matthew Laudon, Executive Director of the Nano Science and Technology Institute. "We are very pleased that Merck, one of the world's most prominent pharmaceutical companies, has partnered with our conference to help address their company's advanced research needs."
To participate in the Merck Corporate Symposium, please submit your abstract through the NSTI Nanotech On-Line Abstract Submission form. The abstract deadline is December 6th, 2007.
The Nano Science and Technology Institute (NSTI) is chartered with the promotion and integration of nano and other advanced technologies through education, technology and business development. NSTI accomplishes this mission through its offerings of continuing education programs, scientific and business publishing and community outreach. NSTI produces the annual Nanotech conference and trade show, the most comprehensive international nanotechnology convention in the world. NSTI also produces the semi-annual Nanotech Venture, Nanotech Industrial Impact Workshop, Nano Impact Summit and the Nanotech Course Series in the US and Europe. NSTI was founded in 1997 as a result of the merger between various scientific societies, and is headquartered in Cambridge, Massachusetts with additional offices in California and Switzerland.
For more information, please click here
696 San Ramon Valley Blvd., Ste. 423
Danville, CA 94526
Ph: (925) 901-4959
Fax: (925) 886-8461
Copyright © NSTI
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Nanoscale assembly line August 29th, 2014
Copper shines as flexible conductor August 29th, 2014
Novel 'butterfly' molecule could build new sensors, photoenergy conversion devices August 28th, 2014
PetLife Comments on CNN Story on Scorpion Venom Health Benefits August 27th, 2014
A new, tunable device for spintronics: An international team of scientists including physicist Jairo Sinova from the University of Mainz realises a tunable spin-charge converter made of GaAs August 29th, 2014
Nanoscale assembly line August 29th, 2014
New analytical technology reveals 'nanomechanical' surface traits August 29th, 2014
New Vice President Takes Helm at CNSE CMOST: Catherine Gilbert To Lead CNSE Children’s Museum of Science and Technology Through Expansion And Relocation August 29th, 2014
SouthWest NanoTechnologies CEO Dave Arthur to Discuss “Carbon Nanotubes and Automotive Applications” at The Automotive Composites Conference and Expo 2014 (ACCE2014) August 28th, 2014
Aspen Aerogels, Inc. to Present at Barclays CEO Energy-Power Conference August 27th, 2014
Malvern specialists to deliver inaugural short course on polymer characterization at Interplas 2014 August 27th, 2014
Wyatt Technology’s 24th International Light Scattering Colloquium to Highlight Developments in Applications and Characterization of Nanoparticles August 21st, 2014